Amyloidosis Center – BUSM, Boston Medical Center

Patient Information

Unique in its approach, the Amyloidosis Center provides exceptional care for patients with all forms of systemic and localized amyloidosis through the support of laboratory and clinical research

In BMC Amyloid clinic with patient and 4 members of the transplant team smiling

Support Amyloidosis Research & Clinical Innovation

Our laboratory and clinical research is supported by grants from the government and from foundations, and by individual donations. These are vital for support of our mission to help us in our quest for a cure for amyloidosis.

Donate Now

Researchers and Physicians

Amyloidosis News

Intellia’s first CRISPR gene editing therapy shows promise in small study

"Intellia Therapeutics has moved one step closer to its ambition of creating one-and-done gene-editing treatments for people with genetic diseases. Last August, the Cambridge company and its partner, Regeneron Pharmaceuticals, published a landmark study showing that even low doses of their one-time treatment based on CRISPR-Cas9 technology could dramatically reduce levels of a disease-causing protein […]

Read more
View All